2,171
Views
11
CrossRef citations to date
0
Altmetric
Clinical Research

The impact of co-morbidities on a 6-year survival after methanol mass poisoning outbreak: possible role of metabolic formaldehyde

, , , , , , , , , , , , , , , & show all
Pages 241-253 | Received 21 Mar 2019, Accepted 24 Jun 2019, Published online: 12 Jul 2019

References

  • Hassanian-Moghaddam H, Nikfarjam A, Mirafzal A, et al. Methanol mass poisoning in Iran: role of case finding in outbreak management. J Public Health. 2015;37:354–359.
  • Nurieva O, Diblik P, Kuthan P, et al. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191:100–115.
  • Rulisek J, Balik M, Polak F, et al. Cost-effectiveness of hospital treatment and outcomes of acute methanol poisoning during the Czech Republic mass poisoning outbreak. J Crit Care. 2017;39:190–198.
  • Zhang G, Grews K, Wiseman H, et al. Application to include fomepizole on the WHO model list of essential medicines. 2015 [cited 2015 Aug 3]. Available from: http://www.who.int/selection_medicines/committees/expert/19/applications/Fomepizole_4_2_AC_Ad.pdf
  • Hovda KE, Hunderi OH, Tafjord AB, et al. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med. 2005;258:181–190.
  • Paasma R, Hovda KE, Tikkerberi A, et al. Methanol mass poisoning in Estonia: outbreak in 154 patients. Clin Toxicol. 2007;45:152–157.
  • Zakharov S, Pelclova D, Urban P, et al. Long-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clin Toxicol. 2015;53:884–892.
  • Nurieva O, Hubacek JA, Urban P, et al. Clinical and genetic determinants of chronic visual pathway changes after methanol – induced optic neuropathy: four-year follow-up study. Clin Toxicol. 2018;17:1–11.
  • Zakharov S, Kotikova K, Vaneckova M, et al. Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions. Basic Clin Pharmacol Toxicol. 2016;119:228–238.
  • Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of clinical toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415–446.
  • Paasma R, Hovda KE, Hassanian-Moghaddam H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes – a multicenter study. Clin Toxicol. 2012;50:823–831.
  • Zakharov S, Pelclova D, Urban P, et al. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann Emerg Med. 2016;68:52–61.
  • Zakharov S, Kurcova I, Navratil T, et al. Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic Clin Pharmacol Toxicol. 2015;116:445–451.
  • Zakharov S, Nurieva O, Kotikova K, et al. Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning. Monatsh Chem. 2017;148:409–419.
  • Desai T, Sudhalkar A, Vyas U, et al. Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmol. 2013;131:358–364.
  • Drangsholt E, Vangstad M, Zakharov S, et al. The hypothesis of circulus hypoxicus and its clinical relevance in patients with methanol poisoning – an observational study of 35 patients. Basic Clin Pharmacol Toxicol. 2018;123:749–755.
  • Hassanian-Moghaddam H, Pajoumand A, Dadgar SM, et al. Prognostic factors in methanol poisoning. Hum Exp Toxicol. 2007;26:583–586.
  • Megarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005;31:189–195.
  • Nurieva O, Kotikova K, Urban P, et al. Prevalence, dynamics, and biochemical predictors of optic nerve remyelination after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:239–249.
  • Sanaei-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol. 2011;49:102–107.
  • Hassanian-Moghaddam H. Prioritizing the intoxicated patients for extracorporeal treatments in methanol poisoning. Crit Care Med. 2015;43:e210–e211.
  • Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–1251.
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
  • Zakharov S, Pelclova D, Urban P, et al. Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features. Clin Toxicol. 2014;52:1013–1024.
  • Zakharov S, Nurieva O, Kotikova K, et al. Factors predicting optic nerve axonal degeneration after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:251–261.
  • Urban P, Zakharov S, Diblik P, et al. Visual evoked potentials in patients after methanol poisoning. Int J Occup Med Environ Health. 2015;29:471–478.
  • Vaneckova M, Zakharov S, Klempir J, et al. Imaging findings after methanol intoxication (cohort of 46 patients). Neuro Endocrinol Lett. 2015;36:737–744.
  • Bezdicek O, Michalec J, Vaneckova M, et al. Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective. Alcohol. 2017;59:27–35.
  • Peterová K, Brožová H, Klempíř J, et al. Gait and balance impairment after acute methanol poisoning. Basic Clin Pharmacol Toxicol. 2018;122:176–182.
  • Vaneckova M, Zakharov S, Klempir J, et al. Methanol intoxication on magnetic resonance imaging – case reports. Cesk Slov Neurol N. 2014;77:235–239.
  • Bezdicek O, Klempir J, Liskova I, et al. Sequelae of methanol poisoning for cognition. Cesk Slov Neurol N. 2014;77/110:320–325.
  • Zakharov S, Kotikova K, Nurieva O, et al. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol. 2017;55:249–259.
  • Paasma R, Hovda KE, Jacobsen D. Methanol poisoning and long term sequelae – a six years follow-up after a large methanol outbreak. BMC Clin Pharmacol. 2009;9:5.
  • Zakharov S, Pelclova D, Navratil T, et al. Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning. Kidney Int. 2014;86:199–207.
  • Zakharov S, Pelclova D, Navratil T, et al. Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning. Clin Toxicol. 2017;55:123–132.
  • Zakharov S, Rulisek J, Nurieva O, et al. Intermittent versus continuous renal replacement therapy in acute methanol poisoning: comparison of clinical effectiveness in mass poisoning outbreaks. Ann Intensive Care. 2017;7:77.
  • Zakharov S, Pelclova D, Navratil T, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol. 2015;53:797–806.
  • Zakharov S, Navratil T, Pelclova D. Fomepizole in the treatment of acute methanol poisonings: experience from the Czech mass methanol outbreak 2012–2013. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158:641–649.
  • Zakharov S, Navratil T, Salek T, et al. Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:666–676.
  • Hubacek JA, Jirsa M, Bobak M, et al. Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humans. Clin Genet. 2018;94:445–449.
  • International Agency for Research on Cancer (June 2004). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 88 (2006): Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. Available from: http://monographs.iarc.fr/ENG/Monographs/vol88/index.php
  • National Toxicology Program (June 2011). Report on Carcinogens, Twelfth Edition. Department of Health and Human Services, Public Health Service, National Toxicology Program. Available from: http://ntp.niehs.nih.gov/go/roc12
  • Hlusicka J, Loster T, Lischkova L, et al. Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning. Clin Toxicol. 2018;56:893–903.
  • Hlusicka J, Loster T, Lischkova L, et al. Markers of nucleic acids and proteins oxidative damage in acute methanol poisoning. Monatsh Chem. 2019;150:477–487.
  • Hlusicka J, Loster T, Lischkova L, et al. Reactive carbonyl compounds, carbonyl stress and neuroinflammation in methyl alcohol intoxication. Monatsh Für Chem. 2019; in press.
  • Leong DP, Smyth A, Teo KK, et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study. Circulation. 2014;130:390–398.
  • Mostofsky E, Chahal HS, Mukamal KJ, et al. Alcohol and immediate risk of cardiovascular events: a systematic review and dose-response meta-analysis. Circulation. 2016;133:979–987.
  • D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.
  • Zakharov S, Hlusicka J, Nurieva O, et al. Neuroinflammation markers and methyl alcohol induced toxic brain damage. Toxicol Lett. 2018;298:60–69.
  • Zamani N, Hassanian-Moghaddam H, Roberts D, et al. Consensus statements on the approach to patients in a methanol poisoning outbreak. Clin Toxicol. 2019; accepted for publication. doi:10.1080/15563650.2019.1636992